Blueprint Medicines Ownership | Who Owns Blueprint Medicines?
Blueprint Medicines Ownership Summary
Blueprint Medicines is owned by 105.24% institutional investors, 0.92% insiders. Blackrock is the largest institutional shareholder, holding 10.58% of BPMC shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.26% of its assets in Blueprint Medicines shares.
BPMC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Blueprint Medicines | 105.24% | 0.92% | -6.16% |
| Sector | Healthcare Stocks | 47.12% | 8.13% | 44.75% |
| Industry | Biotech Stocks | 45.36% | 7.98% | 46.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.65M | 10.58% | $716.45M |
| Vanguard group | 6.54M | 10.40% | $704.72M |
| Price t rowe associates inc /md/ | 5.87M | 9.34% | $633.03M |
| Fmr | 4.83M | 7.69% | $520.97M |
| Wellington management group llp | 3.24M | 5.15% | $348.73M |
| State street | 2.38M | 3.79% | $256.50M |
| William blair investment management | 1.59M | 2.54% | $171.79M |
| Geode capital management | 1.46M | 2.32% | $157.33M |
| Macquarie group | 1.31M | 2.09% | $141.41M |
| Jpmorgan chase | 1.22M | 1.95% | $131.99M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 114.60K | 11.91% | $12.35M |
| Ally bridge group (ny) | 75.64K | 4.86% | $8.15M |
| Orion investment | 108.79K | 4.67% | $11.73M |
| Integral health asset management | 340.00K | 3.48% | $36.65M |
| First turn management | 184.90K | 3.24% | $19.93M |
| Dafna capital management | 104.76K | 2.70% | $11.29M |
| Casdin capital | 326.38K | 2.69% | $35.18M |
| Avidity partners management lp | 383.00K | 1.75% | $41.28M |
| Emerald mutual fund advisers trust | 278.33K | 1.57% | $30.00M |
| Emerald advisers | 341.20K | 1.54% | $36.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 592.13K | 0.01% | 592.13K |
| 1832 asset management | 502.65K | 0.04% | 502.40K |
| Vanguard group | 6.54M | 0.01% | 228.49K |
| Holocene advisors, lp | 943.46K | 0.42% | 228.16K |
| Clearbridge investments | 220.98K | 0.02% | 220.98K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 3.24M | 0.06% | -939.60K |
| Pictet asset management sa | 1.13M | 0.14% | -737.24K |
| Morgan stanley | 421.26K | 0.00% | -637.43K |
| Point72 asset management | - | - | -501.58K |
| Price t rowe associates inc /md/ | 5.87M | 0.08% | -377.43K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 592.13K | 0.01% | 592.13K | $63.82M |
| Clearbridge investments | 220.98K | 0.02% | 220.98K | $23.82M |
| First turn management | 184.90K | 3.24% | 184.90K | $19.93M |
| Massachusetts financial services co /ma/ | 169.54K | 0.01% | 169.54K | $18.27M |
| Orion investment | 108.79K | 4.67% | 108.79K | $11.73M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -4.00 |
| Rakuten securities | -5.00 |
| Innealta capital | -6.00 |
| Hollencrest capital management | -30.00 |
| Stephens consulting | -33.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 329 | 7.17% | 66,148,228 | 1.60% | 105 | 0.94% | 167 | 8.44% | 101 | 9.78% |
| Mar 31, 2024 | 307 | 9.64% | 65,103,888 | 1.92% | 105 | 0.95% | 154 | 22.22% | 92 | -3.16% |
| Dec 31, 2023 | 280 | 19.66% | 63,876,902 | -0.34% | 105 | 0.95% | 126 | 5.88% | 95 | 63.79% |
| Sep 30, 2023 | 234 | - | 64,096,311 | 0.45% | 105 | 0.95% | 119 | 13.33% | 58 | -23.68% |
| Jun 30, 2023 | 234 | 2.63% | 63,810,873 | 0.83% | 105 | 0.95% | 105 | -12.50% | 76 | 20.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 2.06M | 3.26% | -7.34K |
| T. Rowe Price New Horizons | 2.06M | 3.26% | -6.50K |
| Vanguard Total Stock Mkt Idx Inv | 1.99M | 3.13% | -8.83K |
| Vanguard Health Care Inv | 1.80M | 2.84% | 293.20K |
| iShares Russell 2000 ETF | 1.62M | 2.55% | -3.64K |
| Vanguard Small Cap Index | 1.59M | 2.50% | 3.10K |
| T. Rowe Price Health Sciences | 1.46M | 2.31% | 143.76K |
| SPDR® S&P Biotech ETF | 1.29M | 2.03% | 14.29K |
| Vanguard Institutional Extnd Mkt Idx Tr | 950.31K | 1.50% | -11.13K |
| Delaware Small Cap Core I | 908.17K | 1.43% | -5.63K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 07, 2024 | Albers Jeffrey W. | - | Sell | $510.00K |
| Oct 03, 2024 | Namouni Fouad | PRESIDENT, R & D | Sell | $324.50K |
| Sep 09, 2024 | Albers Jeffrey W. | - | Sell | $658.32K |
| Sep 09, 2024 | Albers Jeffrey W. | - | Sell | $1.03M |
| Aug 15, 2024 | Landsittel Michael | CHIEF FINANCIAL OFFICER | Sell | $419.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 21 |
| 2024 Q1 | - | 35 |
| 2023 Q4 | - | 15 |
BPMC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools